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Abstract. Amyloid- peptide (A) aggregates induce nitro-oxidative stress, contributing to the characteristic neurodegeneration
found in Alzheimer’s disease (AD). One of the most strongly nitrotyrosinated proteins in AD is the triosephosphate isomerase
(TPI) enzyme which regulates glycolytic flow, and its efficiency decreased when it is nitrotyrosinated. The main aims of this
study were to analyze the impact of TPI nitrotyrosination on cell viability and to identify the mechanism behind this effect.
In human neuroblastoma cells (SH-SY5Y), we evaluated the effects of A42 oligomers on TPI nitrotyrosination. We found an
increased production of methylglyoxal (MG), a toxic byproduct of the inefficient nitro-TPI function. The proapoptotic effects
of A42 oligomers, such as decreasing the protective Bcl2 and increasing the proapoptotic caspase-3 and Bax, were prevented
with a MG chelator. Moreover, we used a double mutant TPI (Y165F and Y209F) to mimic nitrosative modifications due to A
action. Neuroblastoma cells transfected with the double mutant TPI consistently triggered MG production and a decrease in cell
viability due to apoptotic mechanisms. Our data show for the first time that MG is playing a key role in the neuronal death induced
by A oligomers. This occurs because of TPI nitrotyrosination, which affects both tyrosines associated with the catalytic center.
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INTRODUCTION
Amyloid- peptide (A) aggregates produce free
radicals [1–3] that damage membrane proteins such
as ATPases and ion channels, leading to an increase
in intracellular calcium levels [4, 5]. Under these
conditions, nitric oxide (NO) is produced by the
activation of the neuronal NO synthase (nNOS), a
Ca2+-calmodulin-dependent enzyme [6, 7]. NO can
react with other molecules such as superoxide anion
(O2−) to form peroxynitrite anion (ONOO−) [8], a
short-lived but highly reactive molecule that nitroty-
rosinates proteins. This modification is an irreversible
reaction that adds a nitro group (NO2) to a tyrosine
residue, generating 3-nitrotyrosine [9, 10]. Conse-
quently, nitrotyrosination is widespread in Alzheimer’s
disease (AD) brain [11, 12]. Antioxidants such as
free radical scavengers [13] or inhibitors of NO pro-
duction have been proposed to protect against A
toxicity [14].
One of the proteins strongly nitrotyrosinated by A
action is triosephosphate isomerase (TPI) [15, 16]. TPI
catalyzes the interconversion of D-glyceraldehyde-3-
phosphate to dihydroxyacetone phosphate (DHAP).
A key enzyme in cell metabolism, TPI controls
glycolytic flow and ensures efficient energy produc-
tion [17], which is essential to support normal cell
activity.
Glucose is the primary source of energy for the
brain. Any interruption of glycolysis causes brain dys-
function and memory loss, favoring neurodegeneration
[18]. Isomerase deficiency is associated with neu-
rodegeneration [19] and has been related to reduced
longevity [20]. Moreover, TPI deficiency leads to the
accumulation of its substrate DHAP, which can decom-
pose non-enzymatically into methylglyoxal (MG),
a cytotoxic precursor of advanced glycation end-
products (AGEs) [21]. MG acts as a potent glycative
agent that triggers apoptosis in neurons [22, 23]. Pro-
tein glycation has been previously reported in AD
brains [16, 24] and it would be contributing to the
neuronal damage [25].
In AD patients, TPI is highly nitrotyrosinated [16,
26, 27]. We have previously reported that TPI nitroty-
rosination by A action reduces the efficiency of its
isomerase activity and leads TPI to adopt a -sheet
structure that favors tau aggregation into paired helical
filaments, one of the AD hallmarks [16].
The present study analyzed the impact of nitro-
TPI on cell viability, proposing MG production as
the mechanism behind the deleterious consequences
of A-dependent TPI nitrotyrosination. We analyzed
the toxic effects of treating neuroblastoma cells (SH-
SY5Y) with A42 oligomers. In addition, we studied
the effect of Tyr165 and Tyr209 nitration, located close
to the catalytic center of the enzyme, using the Phe
mutation of Tyr that mimics the nitro-TPI structure.
A computationally validated model of nitro-TPI was
used to analyze its effects.
MATERIALS AND METHODS
Tissue samples
Human brain tissue sections were supplied by
the Banc de Teixits Neurolo`gics, Serveis Cient´ifico-
Te`cnics, Hospital Cl´inic, Universitat de Barcelona.
Brain samples were obtained from the gyrus frontalis
superior of the frontal cortex of five healthy individu-
als (3 males and 2 females aged 59.6 ± 6.9 aged years)
and five patients with AD, at stage VI (2 males and
3 females; aged 72 ± 4.5 years). Human brain sam-
ple analysis was approved by the Ethics Committee
for Clinical Investigation of the Institut Munici-
pal d’Investigacions Me´diques, Universitat Pompeu
Fabra (IMIM-UPF Approval ID: 2010/3847/I). Writ-
ten informed consent was obtained for all study
participants.
Immunohistochemistry of human brain samples
Frontal cortex sections (5m) were pre-treated with
50% formic acid for 1 min to expose TPI epitopes.
Sections were incubated with rabbit anti-TPI poly-
clonal antibody (Ab) (1 : 500, Abcam, Cambridge, UK)
or anti-argpyrimidine Ab (1 : 500, Cosmo Bio Co.,
Ltd, Tokyo, Japan) for 2 h at room temperature (RT),
then incubated with donkey anti-rabbit peroxidase-
conjugated Ab (1 : 500) for 1 h at RT. Slides were
treated with a DAB peroxidase substrate kit (Vector
Lab). Samples were counterstained with hematoxylin,
dehydrated, and mounted.
Mice brain samples
Cerebral paraffined slides from APPswe/PS1
L166P mice were deparaffined with Clear Rite 3
and washed with decreasing ethanol dilutions. Briefly,
slides were blocked for 1 h at room temperature with
2% normal serum in TNB buffer. The same solu-
tion was used to dilute (1 : 100) the anti-argpyrimidine
(Cosmobio) antibody. The primary antibody was incu-
bated overnight at 4◦C. The secondary antibody
M. Tajes et al. / Methylglyoxal in Aβ-Induced Apoptosis 275
was further diluted (1 : 200). All washes were per-
formed with TNT 1X buffer. Mice dissection followed
E.U. guidelines for animal experimentation and was
approved by the Ethics Committee for Animal
Experimentation (IMIM-UPF; Approval ID: JMC-07-
1001P1-PML).
Overexpression of TPI in neuroblastoma cells
TPI was amplified by PCR from purified human
chromosomal DNA and cloned into a construct
containing a 5’ upstream flag sequence. Wild-type
(WT) TPI and TPI carrying double tyrosine mutation
(Y165F/Y209F) were produced and subcloned into a
pcDNA3 plasmid. A human neuroblastoma cell line
(SH-SY5Y) was seeded in 6-well plates at a den-
sity of 5 × 105 cells per well and grown for 24 h
with Ham’s F12 medium supplemented with 15% fetal
bovine serum (FBS). Afterwards, 2g per well of
each construct were transfected using Lipofectamine
2000 Reagent (Invitrogen, Carlsbad, USA), following
manufacturer instructions. After 3 h, the medium was
replaced by Ham’s F12 medium plus 15% FBS and 1%
penicillin/streptomycin.
Aβ42 oligomer preparation
Synthetic A42 (EZBiolab, Carmel, USA)
oligomers were obtained by dissolving 300g freeze-
dried aliquots in 20L DMSO. Peptide stock aliquots
were diluted in 0.1 M Tris-HCl at pH 7.4 to a final
concentration of 88.6M A. Solutions were stirred
continuously at 37◦C and 300 rpm for 3 h and kept at
−80◦C before being used (Supplementary Figure 1).
Aβ42 oligomer incubation with human
neuroblastoma cells
SH-SY5Y, a human neuroblastoma cell line (sup-
plied by ECACC), was grown in Ham’s F12 medium
(Invitrogen) supplemented with 15% FBS and 1%
streptomycin/penicillin at 37◦C in a humidified atmo-
sphere containing 5% CO2. For cell viability and
metabolism assays, cells were seeded into 96-well cul-
ture plates at a density of 25,000 cells/200L per well.
For western blot analysis, cells were plated onto 60
mm-diameter-dishes at a density of 700,000 cells/3 mL
per dish.
After 24 h in culture, cells were treated with dif-
ferent concentrations of A oligomers (0.1, 0.5, and
1M) for 24 h. Then the cells were lysed on ice with
a solution containing 1 M Tris-HCl, 1% Nonidet P-40,
150 mM NaCl, 5 mM EDTA, 1 mM sodium ortho-
vanadate, 1 mM dithiotreitol, pH 7.4, and a protease
inhibitor cocktail (Roche). Protein concentration was
determined by Bradford assay.
Treatment of SH-SY5Y with hydrogen peroxide
(H2O2), camptothecin, and scrambled Aβ
Cells were treated with different concentrations
of scrambled WT A42 prepared as the WT A42
(0.1, 0.5 and 1M; rPeptide; Stratech Scientific), the
pro-apoptotic inhibitor of DNA topoisomerase I camp-
tothecin (10, 100, 500, and 1000 nM; Sigma) and
H2O2, (1, 10, 100, and 200M; Sigma) for 24 h.
Treatment of SH-SY5Y with aminoguanidine (AG)
Cells were pre-treated with the MG scavenger AG
(Sigma) at 250M for 1 h before the addition of A
oligomers for a 24 h treatment. In transfected cells, AG
was added at the beginning of transfection.
Incubation of SH-SY5Y overexpressing WT TPI
with conditioned medium
Cells overexpressing WT TPI were incubated during
24 h with the medium from cells overexpressing WT
or YY TPI (conditioned medium).
TPI immunoprecipitation
500g of total protein from brains or SH-SY5Y
cells lysates were incubated with 1.25g of anti-TPI
polyclonal Ab o.n. at 4◦C. Protein G immobilized on
sepharose was added and samples were shaken for 2 h
at RT. Aggregates were pulled down by centrifugation
at 10,000 rpm for 10 min and washed thrice. Protein G
and Ab were seperated from the immunoprecipitated
proteins by boiling the samples for 6 min at 100◦C.
Western blot
For analysis of cell homogenate aliquots, gels were
transferred to PVDF membranes and incubated for 3 h
at room temperature with one of 7 solutions: mouse
anti-argpyrimidine monoclonal Ab (1 : 1,000; Cosmo
Bio Co., Ltd), mouse anti-nitrotyrosine monoclonal
Ab (1 : 1,000; Cayman Chemical, Michigan, USA),
rabbit anti-cleaved caspase-3 (Asp175) Ab, rabbit anti-
Bax Ab (1 : 1,000; Cell Signaling, Beverly, USA),
mouse-anti TPI Ab (1 : 1,000; Abcam), rabbit anti
Bcl-2 Ab (1 : 1,000; Cell Signaling), or mouse anti-
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Fig. 1. TPI nitrotyrosination by A and MG production. A) Western blot of immunoprecipitated TPI from AD patient and non-demented (CT)
frontal cortex. Quantifications are expressed as arbitrary units (AU). Data are mean ± SEM of 4 independent experiments. ∗∗∗p < 0.001 versus
control by Student’s t-test. B) A representative image of intracellular TPI aggregates in AD frontal cortex analyzed by immunohistochemistry.
C) Western blot of immunoprecipitated TPI from SH-SY5Y cells treated with increasing concentrations of A42 oligomers for 24 h. Blots
were performed with anti-nitrotyrosine and anti-TPI Abs. Data are mean ± SEM of 3 independent experiments. ∗p < 0.05, ∗∗p < 0.01 versus
control by Student’s t-test. D) AD patient and non-demented frontal cortex sections immunostained with an anti-argpyrimidine Ab. Positive
staining is shown in AD patient (arrows). E) Hippocampus from double transgenic mice overexpressing APP and PS1 immunostained with
an anti-argpyrimidine Ab. F) Representative western blot of SH-SY5Y cells challenged with 1M A42 oligomers for 24 h. Glycation was
analyzed using anti-argpyrimidine Ab.
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-actin monoclonal Ab (1 : 5,000, Sigma, St. Louis,
USA). Membranes were incubated with peroxidase-
conjugated secondary Ab (1 : 3,000; GE-Healthcare,
UK) for 1 h at RT. Bands were visualized using the
enhanced chemiluminescence substrate (Super Signal;
Pierce).
Immunocytochemistry of SH-SY5Y
After 24 h, cells were fixed with 4% paraformalde-
hyde and permeabilized with 0.1% Triton X-100.
SH-SY5Y cells were immunostained with 1 : 100
mouse monoclonal anti-methylglyoxal Ab (Cosmo Bio
Co., Ltd.) and 1 : 2,000 Alexa 555-bound as secondary
Ab (Sigma) at RT. Transfected cells were positive for
EGFP fluorescence. Coverslips were mounted and ana-
lyzed using a Leica TCS SP confocal microscope and
analyzed with Leica confocal software.
Cell viability assays
SH-SY5Y cells were seeded in 96-well plates at a
density of 25,000 cells/200L, incubated 24 h, and
tested for viability by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) reduction.
Briefly, 11L of MTT stock solution (5 mg/mL) were
added; after 2 h the reaction was stopped with 120L
of DMSO. MTT reduction was determined in a plate
reader spectrophotometer at 540 and 650 nm. Control
cells were taken as 100%.
Measurement of ∆Ψm
SH-SY5Y cells were re-suspended at 106 cells/mL
in PBS with the fluorophore MitoTracker Red
CMXRos (Molecular Probes, Carlsbad, USA). Cells
were incubated for 10 min at 37◦C and analyzed in a
FACScan (Becton Dickinson, CA).
Liquid chromatography-Mass spectrometry
(LC-MS/MS) experiments
Commercial TPI from rabbit (Sigma) was reduced
and alkylated prior to trypsinization in solution. Tryptic
peptides were desalted using C18 type stage tip41 [28]
prior to analysis by reversed phase nano LC-MS/MS
on an Orbitrap Velos (ThermoScientific, Bremen,
Germany) mass spectrometer in higher-energy col-
lisional dissociation (HCD) mode. MS/MS spectra
were extracted using ProteomeDiscoverer 1.3 (Ther-
moScientific, Bremen Germany) and searched against
SwissProt mammalian using MASCOT. Mass toler-
ance of 10 ppm and 20 mDa was used for precursor
and fragment ions, respectively.
Computational modelling of the effect of Phe and
nitroTyr substitutions on Y165 and Y209
Two structures were taken from the PDB as repre-
sentatives of the open and closed states of TPI, namely
1I45 and 1NEY, respectively. The structures were pro-
cessed with the Schrodinger’s Maestro 9.2.109 suite
for missing heavy atoms and hydrogens, as well as
to transform fluoro-tryptophan residues into trypto-
phan. The optimal hydrogen bond network (providing
optimal protonation states to His residues and opti-
mizing the orientation of the protein side chains) was
obtained with the protein preparation wizard in the
same suite. Mutations were then introduced in order
to build the Y165F and Y165n systems from the open-
state wt structure (1I45) and the Y209F and Y209n
systems from the closed-state wt structure (1NEY).
The six structures were independently solvated with
the Impact/soak module in maestro, in a cube of TIP3P
water molecules with 60 × 60 × 60 A˚3 around the mass
center of each protein. We ran 1 ns molecular dynamics
(MD) simulations with periodic boundary conditions
and a 12 A˚ cut-off radius for non-bonded interac-
tions (updating non-bonded lists every 10 steps) on
the different systems, while keeping fixed the protein
atoms in order to relax the water molecule positions.
After MD runs, the final snapshots were taken as
input for the Quantum Mechanics/Molecular Mechan-
ics (QM/MM) runs.
All QM/MM calculations were performed with the
Qsite program, taking as QM region the residues
directly involved in the hydrogen-bonding networks of
interest. This involved residues 164–166 and the side
chain of 169 in the open state and 176–178, 208–210
in the closed state. With these settings, QM regions
included 48 to 74 atoms, depending on the system.
QM/MM minimizations where performed with a trun-
cated Newton optimizer for the MM. A sphere of
radius 10 A˚ was built around the centroid of the QM
region to define the region to be minimized, leaving
fixed throughout the simulation the water molecules
beyond that radius. Density functional theory computa-
tions using the non-local hybrid Becke three-parameter
exchange function (denoted as B3LYP) with the 6-
31G∗ basis set as implemented in Jaguar were chosen
to describe the energy of the QM region and the frozen
orbital method was used to describe the QM-MM inter-
face. Molecular graphics images were produced using
the UCSF Chimera package from the Resource for
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Biocomputing, Visualization, and Informatics at the
University of California, San Francisco (supported by
NIH P41 RR001081).
Genetic study of TPI polymorphisms
The biallelic polymorphism rs2001004, located
in the first intron of the TPI, was selected to be
typed because it has been validated and has an esti-
mated minor allele frequency in European populations
around 0.34 (http://www.hapmap.org). Genotyping
was conducted by TaqMan Assays-on-Demand on the
ABI PRISMs 7900HT Sequence Detection System
(Applied Biosystems, Carlsbad, California), followed
by analysis with SDS 7500 software, version 2.0.1
(Applied Byosystems, Carlsbad, California).
The SNP was typed in 231 individuals diagnosed
with AD (mean age at onset of 76.4 ± 5.6 years,
73.5% women) and 136 cognitively healthy control
individuals (mean age at blood extraction, 71.7 ± 9.4
years; 58% women). For all patients, the diagnosis
was established according to the National Institute on
Neurological Disorders and Stroke, and the Alzheimer
Disease and Related Disorders Association (NINDS-
ADRDA) guidelines [29]. All samples were recruited
from Fundacio´ ACE and written informed consent was
obtained from all participants or surrogates.
Statistical analysis
Data were expressed as the mean ± SEM of the val-
ues from the number of experiments as indicated in the
corresponding figures. Continuous data were evaluated
by Student’s t-test. Genotype and allele frequencies
were estimated by direct counting and were compared
between patients and controls by Chi-square analysis
with one degree of freedom.
RESULTS
TPI nitrotyrosination and the consequent MG
production in AD are due to Aβ action
As previously reported [16], we found that TPI is
highly nitrotyrosinated in the brain of AD patients, as
obtained by western blot and nitrotyrosination quantifi-
cation regarding the protein levels (Fig. 1A), where it
forms big intracellular aggregates (Fig. 1B). Therefore,
we prepared A oligomers, characterized by west-
ern blot analysis (Supplementary Figure 1), and we
found that the challenge of human neuroblastoma cells
with increasing concentrations of A oligomers pro-
duced a proportional increase in TPI nitrotyrosination
(Fig. 1C), reinforcing that TPI nitrotyrosination is due
to A action [15, 30].
MG is synthesized at a very low rate as a by-
product from TPI isomerase activity, but its production
is strongly increased by TPI nitrotyrosination [16].
Specifically, MG binds to and modifies arginine, cys-
teine, and lysine residues in proteins, which causes
a non-enzymatic formation of different AGEs such
as argpyrimidine, N-(carboxyethyl) lysine, hydroimi-
dazolones N-(5-hydro-5-methyl-4-imidazolon-2-yl)-
ornithine, and methyl-glyoxal-lysine dimer [31]. We
studied the glycative modification of arginine to
argpyrimidine as one of the most representative param-
eters of protein glycation due to MG. Here we analyzed
the protein glycation in the cortex from an AD patient,
confirming higher MG production than that of an age-
matched, non-demented control (Fig. 1D); this concurs
with previous results demonstrating protein glycation
in AD brain [16]. Strong labeling for glycation was also
observed in the hippocampus of an AD mouse model
overexpressing APP and PS1 (Fig. 1E). Furthermore,
high levels of protein glycation was obtained when
human neuroblastoma cells were challenged with A
oligomers (Fig. 1F).
Aβ treatment induces apoptosis in human
neuroblastoma cells
A aggregates are supposed to induce the char-
acteristic neurodegeneration that produces AD [32].
Thus we addressed a study of the effects of A
oligomers on apoptosis in human neuroblastoma cells.
First we studied cell viability after 24 h challenges with
increasing concentrations of A oligomers (Fig. 2A).
A oligomers were significantly toxic for neuroblas-
toma cells from 0.1 to 1M and the toxicity was
dose-dependent (Fig. 2A). These experiments were
carried out in parallel with the study on glucose uptake
(Supplementary Figure 2), a parameter of the cell
metabolism state. Glucose uptake was slightly but
significantly reduced with all the A oligomers con-
centrations assayed in a pattern similar to that of cell
viability.
Next we analyzed the reduction in cell viability
induced by A oligomers. One of the early intracel-
lular events that occurs in apoptosis is the abnormal
opening of the mitochondrial transition pore by the
collapse of mitochondrial transmembrane potential
(m), which results in a rapid release of caspase acti-
vators [33]. The pro-apoptotic effector Bax is a major
mediator in this early apoptotic event. Bax levels were
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Fig. 2. Decreased cell viability and enhancement of apoptosis in neuroblastoma cells challenged with A oligomers. A) Cells challenged with
increasing concentrations of A oligomers assayed by MTT reduction. Data are mean ± SEM of 6 independent experiments performed by
triplicate. ∗∗p < 0.01, ∗∗∗p < 0.001 versus control by Student’s t-test. B) Western blot analysis of pro-apoptotic Bax and anti-apoptotic Bcl-2
levels in cells challenged with increasing concentrations of A oligomers. Quantifications expressed as AU are shown in the graphs. Data are
mean ± SEM of 6 independent experiments. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 versus control by Student’s t-test. C) Western blot analysis of
activated caspase-3 levels in cells treated with A (A) at different concentrations. It was quantified and expressed as AU. Data are mean ± SEM
of 6 independent experiments.∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 by Student’s t-test.
significantly increased when human neuroblastoma
cells were challenged with A oligomers (Fig. 2B). On
the other hand, analysis of the protective anti-apoptotic
protein Bcl-2 levels (Fig. 2B) showed that neuroblas-
toma cells had significantly decreased levels of Bcl-2
when challenged by A oligomers, making them more
prone to apoptosis.
Caspase-3 is downstream of the activation of intra-
cellular apoptotic pathways and has been shown to be
elevated in AD model mice [34] and AD patient brains
[35]. As expected after the proapoptotic changes we
observed in mitochondria, A oligomers significantly
increased the levels of active caspase-3 compared to
non-treated human neuroblastoma cells (Fig. 2C).
To confirm that TPI nitrotyrosination results from
the A-induced oxidative stress, we challenged neu-
roblastoma cells with scrambled A42, a scrambled
peptide with the same amino acids as in human
A42, and cell viability was unchanged (Supplemen-
tary Figure 3A). As expected TPI nitrotyrosination
was not increased by scrambled A42 treatment
(Supplementary Figure 3B). Furthermore we chal-
lenged neuroblastoma cells with H2O2, an inducer
of oxidative stress, and camptothecin, a proapoptotic
inhibitor of DNA topoisomerase I. Both compounds
triggered apoptosis (Supplementary Figure 4A, C) but
only H2O2, which generates reactive oxygen species,
induced TPI nitrotyrosination (Supplementary Fig-
ure 4D). To support the relevance of MG in A toxicity,
we preincubated neuroblastoma cells with AG (Fig. 3
and Supplementary Figure 5), a well-known MG scav-
enger [36, 37]. After 24 h challenge with Aoligomers,
we obtained a significant protection in cell viabil-
ity when cells were preincubated with AG (p < 0.01;
280 M. Tajes et al. / Methylglyoxal in Aβ-Induced Apoptosis
Fig. 3. Decreased A toxicity on neuroblastoma cells pretreated with AG, a MG scavenger. A) Cell viability assay by MTT reduction after 24 h
of A treatment. Data are mean ± SEM of 6 independent experiments performed by triplicate. ∗p < 0.001 versus control; ##p < 0.01 versus A
treated cells by Student’s t-test. B) Western blot analysis of Bax and Bcl-2 levels in cells challenged with A oligomers and A plus AG for
24 h. Quantifications expressed as AU are shown in the graphs. Data are mean ± SEM of 6 independent experiments.∗p < 0.001 versus control;
#p < 0.05, ##p < 0.01 versus A treated cells by Student’s t-test. C) Western blot analysis of activated caspase-3 levels in cells treated with
A and A plus AG. It was quantified and expressed as AU. Data are mean ± SEM of 6 independent experiments.∗p < 0.001 versus control;
##p < 0.01 versus A treated cells by Student’s t-test.
Fig. 3A). Moreover, we analyzed the levels of pro-
and anti-apoptotic proteins in the same conditions.
Assayed by western blot, preincubation with AG pro-
duced a significant increase in the protective Bcl-2
levels (p < 0.01; Fig. 3B) and a decrease in the pro-
apoptotics Bax and Caspase-3 (p < 0.05 and p < 0.01,
respectively; Figs. 3B, C).
MG production is due to the nitration of the two
tyrosines close to the catalytic center of the TPI
A oligomers provoke the nitrotyrosination of TPI
and this modified TPI produces an increase in the
harmful byproduct MG [16]. We studied how nitroty-
rosination affects TPI to produce a burst of MG
production. The TPI monomer has four tyrosines:
Tyr47 and Tyr67 stay at the interface of the dimer
in opposite orientations, so tyrosines from different
monomers do not face each other, while the remain-
ing Tyr165 and Tyr209 are interacting in a direct way
and sit very close to the catalytic site, making them crit-
ical elements of catalytic dysfunction (Supplementary
Figure 6).
To analyze the nitration ability of the two tyrosine
residues in close proximity to the catalytic center, we
used a proteomic-based mass spectrometry strategy.
TPI protein was treated with SIN-1 (a peroxynitrite
donor), then trypsinized and analyzed by LC-MS/MS
(Supplementary Figure 7). Peptides assigned as
being nitrated on tyrosine residues were validated
manually: IIY(NO2)GGSVTGATCK (Supplementary
Figure 7A) and VVLAY(NO2)EPVWAIGTGK (Sup-
plementary Figure 7B). The LC-MS/MS experiment
was not designed as a quantitative study. How-
ever, assuming no major difference in ionization and
digestion efficiency of the tyrosine-nitrated peptide
compared to unmodified peptides, we used the area
under the curve for each peptide to estimate the
percentage of a residue that is modified. In our cal-
culations, 5% to 8% of a given tyrosine residue was
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Fig. 4. Computational modelling of the effect of Phe and nitroTyr substitutions on Tyr165 and Tyr209. Equilibrium structures obtained by
hybrid QM/MM optimizations of the regions surrounding the two key hydrogen bonds in which Tyr165 and Tyr209 are, respectively, involved.
The first row corresponds to the region containing the characteristic Y209-A177 HB in the closed state (based on the structure with PDB code
1NEY) in three different systems, namely (A) wt TPI, (B) Y209F, and (C) Y209n, with n = nitrotyrosine. The second row corresponds to the
region containing the characteristic Y165-W169 HB in the open state (based on the structure with PDB code 1I45) in three different systems,
namely (D) wt TPI, (E) Y165F, and (F) Y165n. Images were produced with Chimera.
nitrated in vitro. This percentage is similar to the ∼10%
reported for nitrotyrosination in general in vitro assays
[38].
On the other hand, computer models provide valu-
able understanding of protein activity, structure, and
folding. They can also be used to study conforma-
tional changes induced by mutations or modifications
of the protein and to predict if such alterations could
have an effect on protein enzymatic activity. Hav-
ing demonstrated that both tyrosines can be nitrated
experimentally, we conducted a computational analy-
sis of the conformational impact of nitrotyrosination
on the catalytic domain of the enzyme. In addition,
we confirmed that a double mutant TPI that we have
generated (Y165F/Y209F) mimics this new conforma-
tion and we validated it as a tool for understanding
the impact of nitrotyrosination on cell viability. The
tyrosines were substituted by phenylalanines because
they have a similar size and structure, and Phe is not
able to establish the biochemical interactions with the
surrounding amino acids, as nitro-Tyr does.
The TPI 3D structure defines the so-called “TIM
barrel” fold, a regular eight-fold repeating pattern
of -strands and -helices. Loop 6 is very flexible
and plays an important role in substrate binding and
catalysis [39]. We hypothesized that TPI nitrotyrosina-
tion at Tyr165 and Tyr209 will destabilize the closed
state of loop 6 [16], mainly due to the weakening of
the H-bond interaction Tyr209-Ala177 (Supplemen-
tary Figure 6), and that this affects the efficiency of the
enzyme. Furthermore, the electron withdrawal effect
of the nitro substituent in the phenol ring of tyro-
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Fig. 5. MG production in neuroblastoma cells overexpressing WT or YY TPI. A) Cells were untreated, treated with AG, or incubated with
conditioned media from cells overexpressing WT TPI or YY TPI. Glycation was studied with an anti-argpyrimidine Ab (red staining). pcDNA3
was used as the transfection control. Transfected cells were EGFP positive (green staining). Images were analyzed by confocal microscopy. B)
Cell viability of normal transfected cells or incubated with the conditioned medium from cells overexpressing YY TPI. It was assayed by MTT
reduction. Data are mean ± SEM of 3 independent experiments performed by triplicate. ∗p < 0.01 versus control; #p < 0.01 versus WT TPI by
Student’s t-test.
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Fig. 6. Increased apoptosis in neuroblastoma cells overexpressing double-mutant TPI Y165F/Y209F. A) Cell viability measurement of the
transfected cells. Data are mean ± SEM of 3 independent experiments performed by triplicate. ∗p < 0.01 versus cells overexpressing WT TPI
by Student’s t-test. B) Representative graph of m in cells overexpressing WT TPI or YY TPI assayed by flow cytometry and MitoTracker
staining. The quantification of cells with low m is expressed as percentage of WT TPI. Data are mean ± SEM of 4 independent experiments
performed by triplicate. ∗p < 0.05 versus cells overexpressing WT TPI by Student’s t-test. C, D) Western blot analysis of Bax, Bcl-2 (C) and
caspase-3 (D) levels in cells overexpressing WT TPI or YY TPI. Quantifications expressed as arbitrary units (AU) are shown in the graphs. Data
are mean ± SEM of 4 independent experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 versus cells overexpressing WT TPI by Student’s t-test.
sine must be a related factor. To test this hypothesis
and to understand how the mutation of tyrosine by
phenylalanine may be mimicking the effect of nitroty-
rosination, we performed a battery of hybrid QM/MM
structural calculations on the H-bond network around
Tyr165 and Tyr209. Figure 4 summarizes the results
of the QM/MM calculations, which were conducted
after short MD simulations to relax the positions of
the water molecules in the vicinity of the key hydro-
gen bonds (see Materials and Methods). The figure
is divided in two rows, corresponding to the closed
state of TPI (upper row, Fig. 4A–C) and to its open
state (lower row, Fig. 4D–F). The different subfigures
show the relevant distances defining the hydrogen bond
network after a standard MD protocol to relax the sol-
vent molecules while keeping the substrate (the protein
atoms) fixed, followed by minimization of a complete
QM/MM system centered in the relevant H-bond.
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The results for the closed state (based on simulations
and minimization, PDB code 1NEY, see Materials
and Methods) show a reasonably similar environment
around the Tyr209-Ala177 H-bond interaction in the
different models (Fig. 4A–C). In fact, practically the
same water molecules are found close to the H-bond.
This helps to compare X209-Ala177 distances for the
three systems with X = Tyr, Phe, NTyr. The distance
between the hydroxyl oxygen in Tyr209 and the main
chain N atom in Ala177 slightly increases when mod-
ified by nitrotyrosination of Tyr209, and the linearity
of the H-Bond is also decreased (Fig. 4C). There are
two reasons for this. On one hand, the electron with-
drawal effect of the nitro group decreases the charge
in the hydroxyl oxygen. On the other, the presence of
competitor nitro oxygen essentially delocalizes this H-
bond. Furthermore, the nitro group can exert a steric
effect, which can perturb and destabilize the H-bond
network. The increase in the X209-A177 distance is
slightly larger for the Y209F substitution, as expected
(Fig. 4B).
As for the open state, here the polarity of the envi-
ronment around the Tyr165-Trp169 H-bond changes
drastically in the mutated system Y165F and in the
modified Y165n (with n representing nitrotyrosine)
(Fig. 4D–F). For the wild-type system, the strongly
polar environment produces a relatively mild H-bond
interaction that keeps loop 6 in the open state (Fig. 4D).
When we move to the Y165F mutant or to the nitrated
tyrosine, the situation changes and the environment
becomes relatively non-polar (Fig. 4E–F). This, in
turn, enhances the interaction in the Y165n-W169 sys-
tem, creating a stronger H-bond that may help to keep
loop 6 in its open conformation for longer periods of
time. In the case of the Y165F mutation, removing the
Tyr165 hydroxyl group and reducing the polarity of
the immediate environment helps the Phe165 residue
to approach W169, compacting the system much the
same as Y165n does.
Overall, Y209 and Y165 nitration helps to avoid the
closure of loop 6 and to keep it open, respectively,
producing the effect of increasing KM (lower affinity
of the ligand by its substrate) and decreasing kcat/KM
(lower enzymatic activity) [16].
Increase in MG production in neuroblastoma cells
transfected with the double mutant TPI
TPI nitrotyrosination results in reduced catalytic
activity and increased occupancy of the enzyme by
the substrate, and consequently, a higher production
of toxic MG [16]. TPI prevents MG production by
holding its loop 6 over the catalytic center when the
substrate binds. Nitration of Tyr165 keeps loop 6 open
via a hydrogen bond with Thr168, allowing the entry
of water into the active site, which results in the hydrol-
ysis of the intermediate enediol phosphate that yields
MG.
This hypothesis was supported by the computational
analysis and confirmed using human neuroblastoma
cells overexpressing WT and mutant TPI at Tyr165Phe
and Tyr209Phe (YY TPI), the two nitrated residues
close to the catalytic center (Fig. 5). These mutations
mimic the effect of nitrotyrosination on loop stability.
Cells overexpressing YY TPI showed an increase
in MG production, detected by immunofluorescence
(Fig. 5A) and western blot (Supplementary Figure 8).
MG diffuses easily. We found that cells overexpressing
WT TPI incubated with conditioned medium from cells
overexpressing YY TPI showed wide protein glycation
(Fig. 5A), but the same cells incubated with condi-
tioned medium from cells overexpressing WT TPI did
not show any glycative stress (Fig. 5A). The effects
of MG in cell death were also studied. We observed
a reduction in cell viability when cells overexpress-
ing WT TPI were incubated with medium from cells
overexpressing YY TPI (p < 0.01; Fig. 5B).
Increased apoptotic events in human
neuroblastoma cells overexpressing the double
mutant TPI Y165F/Y209F
Considering that the double mutant Y165F/Y209F
mimicked the MG production induced by A-
mediated TPI nitrotyrosination we analyzed the impact
of mutant TPI expression on cell survival (Fig. 6).
We observed a pattern consistent with a pro-apoptotic
state: significant reduction in cell viability in cells
transfected with the double mutant TPI compared to
the WT TPI transfected cells (Fig. 6A). Moreover,
we studied the apoptotic events, starting with the
m (Fig. 6B). We found that cells overexpressing
double-mutant TPI had lower m compared to cells
overexpressing WT TPI, suggesting a mitochondrial
dysfunction. We also observed a significant increase in
Bax levels and decrease in Bcl-2 in cells overexpress-
ing double-mutant TPI (Fig. 6C). These early apoptosis
events were in accordance with the increase in active
caspase-3 levels we observed in cells transfected with
double-mutant TPI compared to WT-TPI transfected
cells (Fig. 6D). A direct glycative effect on the stud-
ied apoptotic proteins (Bax, Bcl-2 and caspase-3) was
discarded by western blot analysis (Supplementary
Figure 9).
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Table 1
Genotype and allelic distribution of TPI SNP (rs2001004) analyzed
in AD cases and control subjects
AD Cases Controls
Genotypes
AA 105 (0.454) 54 (0.397)
AG 92 (0.398) 64 (0.471)
GG 34 (0.147) 18 (0.132)
Alleles
A 302 (0.654) 172 (0.632)
G 160 (0.346) 100 (0.368)
Genotype and allele frequencies are expressed in brackets. Both
groups were in Hardy-Weinberg equilibrium. Allele A showed an
Odds Ratio of 1.097 (SE 0.159, Confidence Intervals 0.803–1.500)
and a Relative Risk of 1.034 (SE 0.057, Confidence Intervals
0.924–1.137).
No AD genetic risk associated with the TPI gene
Considering that TPI deficiencies have been associ-
ated with pathological neurologic symptoms [19, 21]
we analyzed the possible existence of TPI polymor-
phisms associated with AD (Table 1). As TPI is a
small gene (∼3 kilobases) located in a region with an
estimated recombination rate of 3.0 cM/Mb, the geno-
typing of a single SNP would cover its genetic diversity.
Our analysis did not disclose any significant differ-
ences in genotypes (χ2 = 1.839, p = 0.399) or allelic
frequencies (χ2 = 0.794, p = 0.373) between cases and
controls. These data support that TPI is a highly con-
served protein due to its key role in glycolysis and
any change is discarded rapidly due to its deleterious
effects.
DISCUSSION
Tyrosine nitration, an irreversible post-translational
modification, is increased in AD [11, 12] and the
glycolytic TPI enzyme is one of the most nitroty-
rosinated proteins in this disease [16, 26, 27]. TPI
nitrotyrosination has a major consequence: it reduces
glycolytic flow, which triggers production of MG, a
compound associated with AD [16]. MG is produced
by the formation of big protein aggregates due to
cross-linking and by the decomposition of DHAP; its
toxicity results from its ability to irreversibly modify
proteins, lipids, and nucleic acids [40] (Supplementary
Figure 10).
The TPI monomer has four tyrosines. The first
two—Tyr47 and Tyr67—remain at the interface of
the dimer in opposite orientations, thus tyrosines from
different monomers do not face each other, whereas
the remaining two—Tyr165 and Tyr209—interact
directly, sit very close to the catalytic site, and con-
tribute to loop 6 mobility. Loop 6 is very flexible and
plays a key role in the reactivity of the enzyme [39].
We selected Tyr165 and Tyr209 for study because of
their importance to enzyme efficiency and their role
in MG generation. Our proteomic analysis showed
that both tyrosines were nitrated when exposed to
peroxynitrite.
In the present work, a combination of short classi-
cal MD simulations and QM/MM calculations helped
us to predict the consequences of the nitrative mod-
ification in loop 6 of the TPI. We present a model
showing how TPI nitrotyrosination at Tyr165 and
Tyr209 would destabilize the closed state of the loop,
affecting enzyme efficiency and promoting MG pro-
duction. We also demonstrated that Tyr165Phe and
Tyr209Phe mutations mimic the effect of nitrotyrosina-
tion on loop stability. Both situations were associated
with increased production of the toxic compound, MG,
which has the ability to irreversibly modify proteins,
lipids, and nucleic acids.
When TPI efficiency is reduced, the substrate DHAP
accumulates and is associated with increased MG pro-
duction and, consequently, with protein glycation. It
has been reported that MG rapidly glycates proteins,
damages mitochondria, and induces a pro-oxidant
state similar to that observed in aged cells [41]. This
harmful scenario was present in the AD brain tis-
sue [42] and high MG levels have been found in
cerebrospinal fluid of patients affected by AD [43].
Glycation also has been associated with apoptosis
[22, 23], a pathologic process widely reported in AD
[44]. Moreover, MG cytotoxicity has been associated
with the impairment of cognitive function in diabetes
[45].
We found TPI nitrotyrosination in AD patient cor-
tex and in human neuroblastoma cells treated with A
oligomers. These findings were correlated with high
protein glycation in AD patient cortex, in the hip-
pocampus of double transgenic mice overexpressing
APP and PS1, and in human neuroblastoma cells
treated with A oligomers. These data suggest that
TPI nitrotyrosination is playing a key role in the neu-
rodegeneration triggered by A. Cell viability declined
consistently in human neuroblastoma cells transfected
with the double-mutant TPI, which mimics the molec-
ular effects of TPI nitrotyrosination. These results
confirm existing evidence that apoptosis is the under-
lying mechanism for the neurodegeneration caused by
TPI nitrotyrosination, reported in AD [44, 46] and in
A-induced nitro-oxidative stress [38, 47]. Mitochon-
dria plays an essential role in cell death because the
permeability of the transition pore and the collapse of
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m are the initial stages in intracellular apoptotic sig-
naling [34]. Consistently we obtained a loss of m
in TPI double-mutant cells, which was associated with
an increase in Bax, a classical pro-apoptotic protein
previously reported to be enhanced in AD [23]. We
observed that A oligomers and double-mutant TPI
increased MG production by abnormal TPI function.
Furthermore, we demonstrated that the increase of MG
is related with the toxicity induced by A, resulting in
increased levels of the active pro-apoptotic caspase-3.
Caspase-3 is critical in apoptosis onset and a recent
study links it to enhanced synaptic failure in an AD
mouse model [48], which is a very early event in the
disease onset. All these effects were reverted when
cells were incubated with a MG scavenger, supporting
evidence that MG is one of the most important intracel-
lular mediators of A-induced apoptosis. However, we
cannot discard that other mechanisms are contributing
to A neurodegeneration.
On the other hand, once the MG burst is trig-
gered there is a plethora of targets that could be
glycated including proteins, lipids, and nucleic acids
[40]. One of the most relevant proteins for AD that
can be glycated is tau, whose glycation has been
proposed to favor its hyperphosphorylation and aggre-
gation into neurofibrillary tangles [49–52]. Altogether
this contributes to the characteristic neuronal damage
of AD.
Finally, we analyzed the possibility that some
polymorphisms in the TPI gene [53] could be associ-
ated with AD. Although its mutations correlate with
neurological dysfunction, we observed no associa-
tion between AD and the TPI gene, reinforcing the
importance of post-translational modifications such as
nitrotyrosination in the gene’s observed relationship
with AD onset and progression.
In conclusion, we have obtained the first results sug-
gesting that A oligomers induce neuronal death by
triggering MG production. Increased release of MG is a
direct consequence of TPI nitrotyrosination due to A
action at the two tyrosines located in the catalytic center
of the gene. MG leads to neuronal death by activating
pro-apoptotic intracellular signaling. This finding links
A with neurodegeneration.
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Figure S1. Aß42 oligomer characterization. 
Western blot of Aß42 oligomers. Anti-Aß Ab 
was used to validate the species selected for 
cell treatment. Oligomer bands are shown. 
 
Figure S2. Glucose uptake in neuroblastoma 
cells. Glucose uptake in cells treated with 
increasing concentrations of Aß oligomers. 
Glucose uptake was quantified and expressed as 
(AU). Data are mean ± SEM of 4 independent 
experiments. * p< 0.05, ** p< 0.01 vs control by 
Student t test.  
 
 
 
 
 
 
Figure S3. The scrambled Aβ42 cannot induce the 
nitrotyrosination of TPI. (A) Neuroblastoma cells were 
challenged with increasing concentrations of scrambled 
Aβ42 for 24h. Cell viability was assayed by MTT 
reduction. Data are mean ± SEM of 3 independent 
experiments performed in triplicate. (B) Western blot of 
immunoprecipitated TPI from neuroblastoma cells treated 
with increasing concentrations of scrambled Aβ42 for 24h. 
Blots were performed with anti-nitrotyrosine and anti-TPI 
Abs. Data are mean ± SEM of 3 independent experiments 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure S5. Aminoguanidine dose-response curve. Neuroblastoma cells were treated with increasing 
concentrations of AG. Cell viability was assayed by MTT reduction. Data are mean ± SEM of 3 
independent experiments performed in triplicate. * p<0.01, ** p<0.001 vs control by Student t test. 
 
 
 
 
 
Figure S4. Nitrotyrosination of TPI is due to nitro-oxidative stress. (A) Neuroblastoma cells were 
challenged with increasing concentrations of camptothecin, a proapoptotic compound, and H2O2, a 
pro-oxidant compound, for 24h. Cell viability was assayed by MTT reduction. Data are mean ± SEM 
of 3 independent experiments performed in triplicate. * p<0.05, ** p<0.001 by Student t test. (B) 
Western blot of immunoprecipitated TPI from neuroblastoma cells treated with increasing 
concentrations of camptothecin and H2O2 for 24h. Blots were performed with anti-nitrotyrosine and 
anti-TPI Abs. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. Loop 6 conformational changes in TPI. Image of the loop in the open/closed 
state showing the distances between the amidic nitrogen NH of Ala176 and the Oη 
oxygen of Tyr209 in both states. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S7. Proteomic analysis of TPI nitrotyrosination. TPI was treated in vitro with 
SIN-1 as indicated in the Material and Methods section. Annotated tandem MS (HCD) 
spectra of two tryptic tyrosine nitrosylated peptides originating from TPI are shown: (A) 
IIY(NO2)GGSVTGATCK and (B) VVLAY(NO2)EPVWAIGTGK. In the spectra, 
vertical lines indicate y-ions used for the manual validation of the peptide sequences. 
Deduced peptide sequences (from C-terminal to N-terminal) are inserted above each 
spectrum. Y(NO2) indicate a nitrosylated tyrosine residue. Additional a- and b-ions are 
marked. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure S8. Increased protein glycation in cells o.e. YY TPI. Cells o.e. the double 
mutant TPI Y165F/Y209F were lysed and the total protein was analyzed by Western 
blot using an anti-argpyrimidine Ab. Glycation was quantified and expressed as (AU). 
Data are mean ± SEM of 3 independent experiments. *p<0.05 vs controls by Student t 
test. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S9. Lack of glycation in apoptotic proteins from cells o.e. double-mutant TPI 
Y165F/Y209F. Western blot analysis of Bax (A), Bcl-2 (B) and caspase-3 (C) levels in 
cells o.e. pcDNA3, WT TPI or YY TPI. Blots were performed with anti-argpyrimidine 
and anti-Bax (A), anti-Bcl-2 (B) or anti-caspase-3 (C) Abs. Quantifications expressed as 
arbitrary units (AU) are shown in the graphs. Data are mean ± SEM of 3 independent 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S10. TPI activity in physiological and pathological states. (A) Under 
physiological conditions MG production by the non-enzymatic decomposition of DHAP 
is very low, and the correct function of TPI allows the continuity of the glycolysis 
pathway. (B) Under pathological conditions, Aβ induces TPI nitrotyrosination. This 
posttranslational modification diminishes its efficiency and increases the production of 
the toxic by-product MG, which leads to neuronal apoptosis. 
 
 
 
 
 
